公司資料
Mirum Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- MIRM
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
96.72 USD (+0.43%)
收盤價
最後更新: 2026年8月24日
5.62B USD
市值
股價為何變動
As of Aug 24, 2026, MIRM closed up 0.43% at $96.72. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Mirum Pharmaceuticals is a rare-disease company focused on cholestatic and liver disorders. Its commercial profile is built around specialized therapies for pediatric and orphan indications.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ, Mirum sits in specialty biopharma.
商業模式特徵
The company combines product revenue with label expansion and pipeline growth in liver disease.
生技產業定位
Mirum is a durable rare-disease name whose stock moves on commercial execution and franchise expansion.
未來催化劑
- Mirum's catalysts are Livmarli growth, liver-disease expansion, and any new rare-cholestatic label or commercial step that widens the franchise. The stock improves if the rare-disease base keeps compounding into a broader franchise.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。